BAFNAPH.NS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 May 2024 @ 05:59):

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. The company provides delayed and sustained release, chewable, and orally disintegrating tablets...

Stats
Today's Volume	20 203.00
Average Volume	7 690.00
Market Cap	2.48B
EPS	INR0 ( 2024-02-11 )
Next earnings date	( INR0 ) 2024-05-21
Last Dividend	INR0.600 ( 2013-09-19 )
Next Dividend	INR0 ( N/A )
P/E	21.97
ATR14	INR0.484 (0.46%)

Volume Correlation

Long: 0.21 (neutral)

Short: -0.23 (neutral)

Signal:(48.24) Neutral

Bafna Pharmaceuticals Correlation

10 Most Positive Correlations
BUTTERFLY.NS	0.955
CLNINDIA.NS	0.942
DIAMONDYD.NS	0.936
BAYERCROP.NS	0.935
FSC.NS	0.934
EASTSILK.NS	0.933
INDIAGLYCO.NS	0.93
TATVA.NS	0.929
ROLTA.NS	0.928
AJRINFRA.NS	0.927

10 Most Negative Correlations
HARIOMPIPE.NS	-0.932
CIGNITITEC.NS	-0.921
CONTROLPR.NS	-0.92
SONATSOFTW.NS	-0.918
BECTORFOOD.NS	-0.91
KAYNES.NS	-0.91
CLSEL.NS	-0.91
GEEKAYWIRE.NS	-0.909
TARMAT.NS	-0.904
JMCPROJECT.NS	-0.901

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Bafna Pharmaceuticals Correlation - Currency/Commodity

-0.59
( weak negative )

-0.71
( moderate negative )

-0.65
( weak negative )

-0.67
( moderate negative )

0.23
( neutral )

-0.54
( weak negative )

Bafna Pharmaceuticals Financials

Annual	2022
Revenue:	INR1.15B
Gross Profit:	INR387.56M (33.60 %)
EPS:	INR4.79

FY	2022
Revenue:	INR1.15B
Gross Profit:	INR387.56M (33.60 %)
EPS:	INR4.79

FY	2022
Revenue:	INR851.40M
Gross Profit:	INR338.55M (39.76 %)
EPS:	INR2.17

FY	2021
Revenue:	INR712.18M
Gross Profit:	INR257.62M (36.17 %)
EPS:	INR2.46

Financial Reports:

No articles found.

Bafna Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Bafna Pharmaceuticals Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.98 - low (32.33%) | Divividend Growth Potential Score: 2.71 - No dividend growth expected in the near future

Information

First Dividend	INR0.600	2013-09-19
Last Dividend	INR0.600	2013-09-19
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	INR0.600	--
Avg. Dividend % Per Year	0.00%	--
Score	1.01	--
Div. Sustainability Score	3.98
Div.Growth Potential Score	2.71
Div. Directional Score	3.34	--

Next Divdend (Est)
(2024-05-09)

INR0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

1.01

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR0	0.00%
2019	INR0	0.00%
2020	INR0	0.00%
2021	INR0	0.00%
2022	INR0	0.00%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
TCI.NS	Dividend Junior	2023-07-25	Semi-Annually	23	0.70%
NUCLEUS.NS	Dividend Junior	2023-07-07	Annually	22	1.41%
INDUSINDBK.NS	Dividend Junior	2023-06-02	Annually	23	0.56%
COLPAL.NS	Dividend Knight	2023-05-19	Semi-Annually	18	1.38%
SCI.NS	Dividend Junior	2023-09-01	Sporadic	22	0.25%
MAHSEAMLES.NS	Dividend Junior	2023-08-14	Annually	21	0.80%
GODFRYPHLP.NS	Dividend Junior	2023-08-11	Annually	24	1.52%
AURIONPRO.NS	Dividend Junior	2023-09-22	Sporadic	19	0.36%
TRENT.NS	Dividend Junior	2023-05-25	Annually	21	0.10%
PHOENIXLTD.NS	Dividend Junior	2023-09-15	Annually	18	0.16%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0735	1.500	8.53	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.145	1.500	9.50	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	5.17	1.000	9.20	9.20	[3 - 30]
operatingCashFlowPerShareTTM	4.44	2.00	8.52	10.00	[0 - 30]
freeCashFlowPerShareTTM	4.44	2.00	7.78	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.305	1.000	8.25	8.25	[0.2 - 0.8]
operatingProfitMarginTTM	0.0782	1.000	-0.436	-0.436	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.98

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	22.01	1.000	7.88	0	[1 - 100]
returnOnEquityTTM	0.145	2.50	9.68	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	4.44	2.00	8.52	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	4.44	2.00	8.52	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-2.17	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0685	1.000	-0.788	0	[0.1 - 0.5]
Total Score				2.71

Bafna Pharmaceuticals

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. The company provides delayed and sustained release, chewable, and orally disintegrating tablets. It also exports its products. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India.